Performance evaluation of scoring systems for predicting post-operative hypertension cure in primary aldosteronism.


Journal

Clinical endocrinology
ISSN: 1365-2265
Titre abrégé: Clin Endocrinol (Oxf)
Pays: England
ID NLM: 0346653

Informations de publication

Date de publication:
10 2021
Historique:
revised: 20 04 2021
received: 01 03 2021
accepted: 13 05 2021
pubmed: 28 5 2021
medline: 28 10 2021
entrez: 27 5 2021
Statut: ppublish

Résumé

Hypertension cure following adrenalectomy in unilateral primary aldosteronism is not guaranteed. Its likelihood is associated with pre-operative parameters, which have been variably combined in six different predictive scoring systems. The relative performance of these systems is currently unknown. The objective of this work was to identify the best performing scoring system for predicting hypertension cure following adrenalectomy for primary aldosteronism. Retrospective analysis in a single tertiary referral centre. Eighty-seven adult patients with unilateral primary aldosteronism who had undergone adrenalectomy between 2004 and 2018 for whom complete data sets were available to calculate all scoring systems. Prediction of hypertension cure by each of the six scoring systems. Hypertension cure was achieved in 36/87 (41.4%) patients within the first post-operative year, which fell to 18/71 (25.4%) patients at final follow-up (median 53 months, P = .002). Analysis of receiver operating characteristic area under the curves for the different scoring systems identified a difference in performance at early, but not late, follow-up. For all systems, the area under the curve was lower at early compared with late follow-up and compared to performance in the cohorts in which they were originally defined. No single scoring system performed significantly better than all others when applied in our cohort, although two did display particular advantages. It remains to be determined how best such scoring systems can be incorporated into the routine clinical care of patients with PA.

Identifiants

pubmed: 34042196
doi: 10.1111/cen.14534
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

576-586

Subventions

Organisme : Trustees of the Medical College of St Bartholomew's Hospital

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293-2300. https://doi.org/10.1016/j.jacc.2006.07.059
Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6(1):51-59. https://doi.org/10.1016/S2213-8587(17)30367-4
Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41-50. https://doi.org/10.1016/S2213-8587(17)30319-4
Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5(9):689-699. https://doi.org/10.1016/S2213-8587(17)30135-3
Morisaki M, Kurihara I, Itoh H, et al. Predictors of clinical success after surgery for primary aldosteronism in the Japanese nationwide cohort. J Endocr Soc. 2019;3(11):2012-2022. https://doi.org/10.1210/js.2019-00295
Utsumi T, Kamiya N, Endo T, et al. Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg. 2014;38(10):2640-2644. https://doi.org/10.1007/s00268-014-2612-1
Zarnegar R, Young WF, Lee J, et al. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg. 2008;247(3):511-518. https://doi.org/10.1097/SLA.0b013e318165c075
Wachtel H, Cerullo I, Bartlett EK, et al. Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism. Surgery. 2014;156(6):1394-1403. https://doi.org/10.1016/j.surg.2014.08.021
Hannon M, Sze W, Carpenter R, et al. Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism. QJM. 2017;110(5):277-281.
Wierdak M, Sokołowski G, Natkaniec M, et al. Short- and long-term results of laparoscopic adrenalectomy for Conn’s syndrome. Videosurgery Other Miniinvasive Tech. 2018;13(3):292-298. https://doi.org/10.5114/wiitm.2018.74833
Lo CY, Tam PC, Kung AW, Lam KS, Wong J. Primary aldosteronism. Results of surgical treatment. Ann Surg. 1996;224(2):125-130. https://doi.org/10.1097/00000658-199608000-00003
Burrello J, Burrello A, Stowasser M, et al. The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism. Ann Surg. 2020;272(6):1125-1132. https://doi.org/10.1097/SLA.0000000000003200
Utsumi T, Kawamura K, Imamoto T, et al. High predictive accuracy of Aldosteronoma Resolution Score in Japanese patients with aldosterone-producing adenoma. Surgery. 2012;151(3):437-443. https://doi.org/10.1016/j.surg.2011.08.001
Yang Y, Williams TA, Song Y, et al. Nomogram-based preoperative score for predicting clinical outcome in unilateral primary aldosteronism. J Clin Endocrinol Metab. 2020;105(12):e4382-e4392. https://doi.org/10.1210/clinem/dgaa634
Aronova A, Gordon BL, Finnerty BM, Zarnegar R, Fahey TJ. Aldosteronoma resolution score predicts long-term resolution of hypertension. Surgery. 2014;156(6):1387-1393. https://doi.org/10.1016/j.surg.2014.08.019
Pasquier L, Kirouani M, Fanget F, et al. Assessment of the Aldosteronona resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients. Langenbeck’s Arch Surg. 2017;402(2):309-314. https://doi.org/10.1007/s00423-017-1557-x
Waldmann J, Maurer L, Holler J, et al. Outcome of surgery for primary hyperaldosteronism. World J Surg. 2011;35(11):2422-2427. https://doi.org/10.1007/s00268-011-1221-5
Rossi GP, Bolognesi M, Rizzoni D, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008;51(5):1366-1371. https://doi.org/10.1161/HYPERTENSIONAHA.108.111369
Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266-3281. https://doi.org/10.1210/jc.2008-0104
Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889-1916. https://doi.org/10.1210/jc.2015-4061
Williams B, Mancia G, Spiering W, et al. 2018 Practice guidelines for the management of arterial hypertension of the European society of hypertension and the European society of cardiology: ESH/ESC task force for the management of arterial hypertension. J Hypertens. 2018;36(12):2284-2309.
Lau JHG, Candy Sze WC, Reznek RH, et al. A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. Clin Endocrinol (Oxf). 2012;76(2):182-188. https://doi.org/10.1111/j.1365-2265.2011.04202.x
DeLong E, DeLong D, Clarke-Pearson D. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.
Rossi GP, Maiolino G, Flego A, et al. Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term. Hypertension. 2018;71(4):585-591. https://doi.org/10.1161/HYPERTENSIONAHA.117.10596
Benham JL, Eldoma M, Khokhar B, Roberts DJ, Rabi DM, Kline GA. Proportion of patients with hypertension resolution following adrenalectomy for primary aldosteronism: a systematic review and meta-analysis. J Clin Hypertens. 2016;18(12):1205-1212. https://doi.org/10.1111/jch.12916
Zhou Y, Zhang M, Ke S, Liu L. Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis. BMC Endocr Disord. 2017;17(1):61. https://doi.org/10.1186/s12902-017-0209-z
Rahman ARA, Wang JG, Kwong GMY, Morales DD, Sritara P, Sukmawan R. Perception of hypertension management by patients and doctors in Asia: potential to improve blood pressure control. Asia Pac Fam Med. 2015;14(1): https://doi.org/10.1186/s12930-015-0018-3
Marshall IJ, Wolfe CDA, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345(7867):e3953. https://doi.org/10.1136/bmj.e3953
Sacks GD, Dawes AJ, Ettner SL, et al. Surgeon perception of risk and benefit in the decision to operate. Ann Surg. 2016;264(6):896-903. https://doi.org/10.1097/SLA.0000000000001784
Sacks GD, Dawes AJ, Ettner SL, et al. Impact of a risk calculator on risk perception and surgical decision making: a randomized trial. Ann Surg. 2016;264(6):889-895. https://doi.org/10.1097/SLA.0000000000001750
Nanba K, Omata K, Gomez-Sanchez CE, et al. Genetic characteristics of aldosterone-producing adenomas in blacks. Hypertension. 2019;73(4):885-892. https://doi.org/10.1161/HYPERTENSIONAHA.118.12070
Azizan EAB, Murthy M, Stowasser M, et al. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension. 2012;59(3):587-591. https://doi.org/10.1161/HYPERTENSIONAHA.111.186239
Nishimoto K, Tomlins SA, Kuick R, et al. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci. 2015;112(33):E4591-E4599. https://doi.org/10.1073/pnas.1505529112
Fujii Y, Takeda Y, Kurihara I, et al. Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan. J Hum Hypertens. 2020;34(1):34-42. https://doi.org/10.1038/s41371-019-0229-4

Auteurs

Samuel Matthew O'Toole (SM)

Department of Endocrinology, St Bartholomew's Hospital, London, UK.
The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, UK.

Catherine Hornby (C)

Department of Endocrinology, St Bartholomew's Hospital, London, UK.

Wing-Chiu Candy Sze (WC)

Department of Endocrinology, St Bartholomew's Hospital, London, UK.

Mark John Hannon (MJ)

Department of Endocrinology, St Bartholomew's Hospital, London, UK.
Department of Endocrinology and Diabetes, Bantry General Hospital, Bantry, Cork, Ireland.

Scott Alexander Akker (SA)

Department of Endocrinology, St Bartholomew's Hospital, London, UK.
The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, UK.

Maralyn Rose Druce (MR)

Department of Endocrinology, St Bartholomew's Hospital, London, UK.
The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, UK.

Mona Waterhouse (M)

Department of Endocrinology, St Bartholomew's Hospital, London, UK.

Anne Dawnay (A)

Department of Clinical Biochemistry, Barts Health NHS Trust, London, UK.

Anju Sahdev (A)

Department of Radiology, St Bartholomew's Hospital, London, UK.

Matthew Matson (M)

Department of Radiology, St Bartholomew's Hospital, London, UK.

Laila Parvanta (L)

Department of Endocrine Surgery, St Bartholomew's Hospital, London, UK.

William Martyn Drake (WM)

Department of Endocrinology, St Bartholomew's Hospital, London, UK.
The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH